Key result
Novel KCNQ1-flanking STR markers demonstrate high genetic discrimination across 77 identified haplotypes.
Why the study?
The KCNQ1 gene plays a significant role in heterogeneous cardiovascular disorders including long QT syndrome, Jervell and Lange-Nielsen syndrome, familial atrial fibrillation, and short QT syndrome, prompting the evaluation of novel STR markers around the gene.
Cross-Sectional (n=60)
A novel panel of 6 STR markers around the KCNQ1 gene demonstrated high heterozygosity and discrimination power in an Iranian population, potentially aiding in the genetic diagnosis of related arrhythmogenic disorders.
Answers are grounded in this paper and cite their sources.
STR markers show high heterozygosity in Iranians; leaves open diagnostic utility for KCNQ1 arrhythmogenic disorders.
Background/aim: The KCNQ1 gene has a significant role in long QT syndrome, Jervell and Lange-Nielsen syndrome, familial atrial fibrillation, and short QT syndrome. Analyzing such heterogeneous disorders, six novel short tandem repeat (STR) markers around the KCNQ1 gene were found and evaluated in a healthy population, and other statistical traits of the markers were detected. Materials and methods: Using Tandem Repeats Finder (TRF) and Sequence-Based Estimation of Repeat Variability (SERV) software, STR markers were detected with valid tetra- and pentanucleotide repeats. The markers were investigated for a total of 60 unrelated Iranian healthy individuals and analyzed using GenAlEx 6.502 and Cervus 3.0.7. Results: A total of 77 haplotypes was detected, of which 25 haplotypes were unique and the others occurred at least two times. The number of haplotypes per locus ranged from 7 to 18 with the highest frequency of 69.2%, and the observed heterozygosity was calculated as 0.589. The power of discrimination ranged from 0.70 to 0.96. Five of the markers meet Hardy–Weinberg equilibrium. Conclusion: A novel panel of STR markers was described with high allele heterozygosity and segregation in every locus, which may lead to faster and more credible recognition of the disease-inducing KCNQ1 gene and allow it to be used for human identity testing and prenatal diagnosis.
No takes yet. Share an insight, caveat, or question.
Azam Amirian (2019) conducted a cross-sectional in Healthy individuals (surrogate for KCNQ1-related cardiovascular disorders) (n=60). Novel STR markers flanking the KCNQ1 gene was evaluated on Characterization of heterozygosity, allele frequencies, and power of discrimination of 6 STR markers. Analysis of six novel STR markers surrounding the KCNQ1 gene identified 77 haplotypes with high allele heterozygosity and a power of discrimination ranging from 0.70 to 0.96.
Synapse has enriched 10 related papers. Consider them for comparative context: